Retraction note: Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma
Diagnostic Pathology volume 11, Article number: 111 (2016)
The Editor-in-Chief and Publisher have retracted this article  because the scientific integrity of the content cannot be guaranteed. An investigation by the Publisher found it to be one of a group of articles we have identified as showing evidence suggestive of attempts to subvert the peer review and publication system to inappropriately obtain or allocate authorship. This article showed evidence of plagiarism (most notably from the articles cited [2–4]) and authorship manipulation.
Taheriazam A, Bahador R, Karbasy SH, Jamshidi SM, Torkaman A, Yahaghi E, Shakeri M. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma. Diagn Pathol. 2015;10:166.
Song QC, Shi ZB, Zhang YT, Ji LL, Wang KZ, Duan DP, Dang XQ. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients. Oncology Reports. 2014;31:1263–70.
Xue Z, Zhao J, Niu L, An G, Guo Y, Ni L. Up-regulation of MiR-300 promotes proliferation and invasion of osteosarcoma by targeting BRD7. PLoS ONE. 2015;10(5):e0127682.
Dadpay M, Zarea M, Rabati RG, Rezakhaniha B, Barari B, Ehnod V, Ziari K. Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node metastasis and poor prognosis. Tumour Biol. 2015. doi:10.1007/s13277-015-3905-1.
The online version of the original article can be found under doi:10.1186/s13000-015-0400-3.
About this article
Cite this article
Taheriazam, A., Bahador, R., Karbasy, S.H. et al. Retraction note: Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma. Diagn Pathol 11, 111 (2016). https://doi.org/10.1186/s13000-016-0564-5